TP53 mutation data were aggregated from multiple studies deposited in the cBioPortal database, including the pan-cancer MSK-IMPACT Clinical Sequencing Cohort and all available studies for glioblastoma, pan-CNS cancers, and the top five cancer types by incidence: breast, lung, skin, pancreatic, and colorectal (33). Here, TP53 is linked to cancer.